David Berman

Dr. David Berman

Director, Principal Investigator and Professor , Queen’s Cancer Research Institute, Kingston


David M Berman (Director of Queen's Cancer Research Institute, Principal Investigator, and Professor of Pathology and Molecular Medicine) gave up his role as a New York City bicycle maven to pursue MD and PhD degrees at U.T. Southwestern where he cloned the cDNA for the enzyme 5-alpha reductase and elucidated its role in prostate development. He then performed anatomic pathology and subspecialty training in urologic pathology at Johns Hopkins, followed by a postdoctoral fellowship in Molecular Biology and Genetics.

He ran a research laboratory at Johns Hopkins University for 9 years prior to moving the laboratory to Queen’s University in Kingston Ontario. His research focuses on high impact biomarkers in prostate and bladder cancer. He performs diagnostic surgical pathology one week per month and devotes the rest of his professional efforts to research.

David’s hobbies include playing barista and baking bread for his wife Peggy and his friends and co-workers, wave-jumping with his two daughters, and swimming.

Funded Projects

Next generation non-invasive testing for prostate cancer »

In situ biomarkers of urothelial carcinoma invasion and progression »

Research Specialties

Research Interests

  • Molecular Pathology
  • Urological

Contact for Collaboration

Queen’s Cancer Research Institute
Suite 302, 10 Stuart Street
Kingston, ON, K7L 3N6
Pathologists and Researchers who are interested in being part of the OMPRN: